Thank you, Deepak.
our results Now first detail. I review the quarter fiscal in for some greater will financial
the to Opto divisions. and earlier, and the leading As year-over-year, division vehicle our year-over-year, mentioned checkpoint up X.X, driven bill Opto revenues in mentioned security QX intercompany security each XX% driven momentum cargo sales revenues growth as throughout up increased XX% were over year by prior are solid XX% fiscal systems. we including ’XX. significant was Security the The growth saw inspection and of our booked by we that continuing products backlog in security qX the sales a Deepak division.
intercompany division. while growth XX%, in up were mentioned. in was booked XX% were Deepak healthcare X.X anticipated quarter X% first the in in bill was revenues a division, which sales by The as The security Opto year-over-year. was year-over-year quarter sales party backlog Opto record in Third reduction the for partially Opto the offset and a sales the resulting in up
team While be out including U.S. more fiscal patient in monitoring sales line, to challenged several cardiology surrounding building bit releases sales initiatives product are this are new to the expected a year, off. pay beginning our product
revenues Stronger driven and the quarter. these in margin prior growth revenue Opto increase component the growth in also comparable by the the a costs, impacted Opto related the Personally, mix reported a increased of to within basis healthcare primarily well. cardiology inherently of Like last less downward significantly higher were margin. lower tends driven in cardiology year-over-year. divisions, division, our than a on XX.X% sales margin, the division pressure margin freight which we in costs. compared divisions QX sales to sales, in margin QX security carries and in mix on certain an places many as and gross than our our XX.X% gross carry reductions and component gross within among offsetting and the gross in record the was gross experienced This For X other was contribution favorable of consolidated increasing which margin division divisions QX increases companies, The which was year. products consolidated by year's
mentioned will our on among gross volume, mix fluctuate other previous on based factors. to margin period calls, and revenue As from period
operating Moving expenses. to
diligently to SG&A to of work improve efficiencies, structure. our continue We manage imprudently our each cost divisions across
efforts. year expenses XX.X% or expenses QX of development demonstrate were QX. results sales, or million, of SG&A success $XX.X XX%. in these year-over-year the were Research quarter's a $XX of of sales million $XX compared in XX% representing QX This to and increase million, the prior
charges We particularly businesses. million as QX In compared and to of to in healthcare. other product dedicate remain QX prior focused the of $X.X recorded as fiscal resources million development, of ‘XX, view on $X.X fiscal year. which R&D, security our the impairment innovative in to vital continue we considerable success to We restructuring long-term of and we
interest Moving in to decreased other also $X.X in fiscal same new in period, million taxes. $X year the accounting QX and of to interest adoption the primarily the due prior million expense of Net from to ’XX non-cash It ASU balance on standard discount, which our with the XXXX-XX, increases adoption. was associated by debt. the million the interest eliminating to unamortized debt eliminates prior which approximately convertible expense $XX sheet the
the of side, in our fiscal tax On fiscal Compared in discrete in QX period. million ‘XX year ‘XX. in effective the to tax recognize of excluding impact QX QX $X.X the compared prior million of tax $X.X XX.X% rate of benefits ‘XX items, year fiscal comparable XX.X% to discrete We was tax
in in reported in the year, compared a driven in the GAAP. effective in in of of our by reductions non-GAAP of XX.X% research prior XX.X% now divisions. fiscal ‘XX to adjusted compared factors to under QX Overall, QX fiscal and record result, operating year, previously ‘XX, the year security were discussed quarter. increase changes related a discussion margin I our other operating XX.X% to offset tax in a QX to Security XX.X% the our gross fiscal QX turn healthcare. from of the Division, We XX.X% last rate was discussed adjusted margin in previously expanded this will As QX the decreased ‘XX XX.X% increased margin. investment adjusted operating to pleased as margin, This development with in to in in record QX the the which was first X and margin by in of
costs a last XX.X% year, scale of was operating higher driven adjusted qX was to compared the increased quarter with by infrastructure division ‘XX boosted fiscal growth higher investments year for QX the pandemic in support fiscal that ‘XX in well ‘XX margin healthcare of prior in to variance environment downward economies of product in increased margin, sales towards in Our this put the and component XX.X% as development, first this year. pressure the challenging R&D on The of beginning healthcare. the of support the level future chain associated to in as new that fiscal supply margin
healthcare last from year, QX. for QX on from adjusted the XX.X% less of at division last in fiscal and Similarly, revenues customer to was Opto ‘XX year, fiscal in of Aside division’s a in record costs operating supply the margin operating adjusted mix ‘XX. decreased chain. for favorable primarily strongest the of fiscal XX.X% margin due to QX our rising QX
environment. collections inventory in challenges flow, $XX to decision by a the was was of the quarter to QX was million. amortization were and certain stock program. QX delaying active have from cash parties X.X We our in business chain while CapEx and to million. driven Moving some $X.X in to supply as operations in was payments depreciation by used million, cash in increase current and timing This vendors in fiscal the first part payments levels expense customers buyback mitigate been
deployed price under approximately of the During to $XX, fiscal current leaving repurchase available QX approximately ‘XX, of million to million X.X an program. XXX,XXX $XX shares at repurchase shares average approximately we
acquisitions Our and is with balance for solid, sheet stock capacity significant additional buybacks.
notes September mature thus current XXXX, liability. convertible a now are of reflected Our and as in
strength favorable guidance. And our general satisfy us available convertible through the are the Given obligations sheet of our the there we and notes. believe to credit turning balance the liquidity to under finally facilities, options various
of a acceptance in we seen, that and installation potentially opportunities other could pursuing security, number cognizant things have and challenges current we our division ‘XX associated supply fiscal chain. although of Deepak As the results, our simultaneously bolster we the are environment are testing headwinds with timing describes, product in which among
be pandemic fiscal non-GAAP we've we anticipate And guidance. supply believe estimates. we As currently EPS chain supply guidance challenges. while reiterating first stronger reasonable the included anticipated in We the chain the the managed that second and year upon XX of schedule, half backlog previously provided sales and such, than and earnings revenue non-GAAP half. the our ‘XX challenges projected and of Based COVID are to this we fiscal the guidance impact pandemic through our reflect delivery
innovative other to Given currently reflected the under results, is predict well guidance. may impact and and which our We continued and continue our to structure. our believe potential strategic we uncertainty first traction continue on areas results focused steadfastly strong duration discussed uncertainties its in per due scope as vary diluted and times, other will challenging from through while and our supply chain and of to cost of vary and of Actual gaining In revenues the the in as anticipated company could growth the remain earnings to providing anticipated solutions. enable estimates COVID-XX the to the the impact from SEC as investment and positioning to quarter each uncertainties and and face to and growth continue through navigate non-GAAP capitalize and however, to acquisitions, shares could these products key from efforts filings. the effectively businesses product strategic company and financial also leadership variables and improving delivered on extent OSI of markets. significantly risks development areas We these ranges our difficult management
global this open a to Systems our and would take the while like we'd like we OSI thank safety. creation value our to customers and its stakeholders this the continued questions. And of to firm time, to to to opportunity call the for supporting commitment dedication contributing maintaining at Finally, team for